Trial intelligence / Profile preview

Esketamine for Cholestatic Pruritus in Hepatobiliary Surgery

NCT07760740Not yet recruiting

Sponsor
Tianjin Medical University General Hospital
Start
Aug 2026
Primary completion
Apr 2027
Countries
1
01

Overview

Randomised trial of esketamine in cholestatic pruritus (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Numeric Rating Scale for Pruritus. Planned start Aug 2026; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

cholestatic pruritus

Beyond the preview

Go deeper on NCT07760740.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07760740.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call